Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.

<h4>Background</h4>Postulating that serotonin (5-HT), released from smoking-activated platelets could be involved in smoking-induced vascular modifications, we studied its catabolism in a series of 115 men distributed as current smokers (S), never smokers (NS) and former smokers (FS) who...

Full description

Bibliographic Details
Main Authors: Jean-Marie Launay, Muriel Del Pino, Gilles Chironi, Jacques Callebert, Katell Peoc'h, Jean-Louis Mégnien, Jacques Mallet, Alain Simon, Francine Rendu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-11-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19956754/?tool=EBI
id doaj-560f48c518334ac7bb46feb320e0217d
record_format Article
spelling doaj-560f48c518334ac7bb46feb320e0217d2021-03-03T22:33:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-11-01411e795910.1371/journal.pone.0007959Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.Jean-Marie LaunayMuriel Del PinoGilles ChironiJacques CallebertKatell Peoc'hJean-Louis MégnienJacques MalletAlain SimonFrancine Rendu<h4>Background</h4>Postulating that serotonin (5-HT), released from smoking-activated platelets could be involved in smoking-induced vascular modifications, we studied its catabolism in a series of 115 men distributed as current smokers (S), never smokers (NS) and former smokers (FS) who had stopped smoking for a mean of 13 years.<h4>Methodology/principal findings</h4>5-HT, monoamine oxidase (MAO-B) activities and amounts were measured in platelets, and 5-hydroxyindolacetic acid (5-HIAA)--the 5-HT/MAO catabolite--in plasma samples. Both platelet 5-HT and plasma 5-HIAA levels were correlated with the 10-year cardiovascular Framingham relative risk (P<0.01), but these correlations became non-significant after adjustment for smoking status, underlining that the determining risk factor among those taken into account in the Framingham risk calculation was smoking. Surprisingly, the platelet 5-HT content was similar in S and NS but lower in FS with a parallel higher plasma level of 5-HIAA in FS. This was unforeseen since MAO-B activity was inhibited during smoking (P<0.00001). It was, however, consistent with a higher enzyme protein concentration found in S and FS than in NS (P<0.001). It thus appears that MAO inhibition during smoking was compensated by a higher synthesis. To investigate the persistent increase in MAO-B protein concentration, a study of the methylation of its gene promoter was undertaken in a small supplementary cohort of similar subjects. We found that the methylation frequency of the MAOB gene promoter was markedly lower (P<0.0001) for S and FS vs. NS due to cigarette smoke-induced increase of nucleic acid demethylase activity.<h4>Conclusions/significance</h4>This is one of the first reports that smoking induces an epigenetic modification. A better understanding of the epigenome may help to further elucidate the physiopathology and the development of new therapeutic approaches to tobacco addiction. The results could have a larger impact than cardiovascular damage, considering that MAO-dependent 5-HT catabolism is also involved in addiction, predisposition to cancer, behaviour and mental health.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19956754/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Jean-Marie Launay
Muriel Del Pino
Gilles Chironi
Jacques Callebert
Katell Peoc'h
Jean-Louis Mégnien
Jacques Mallet
Alain Simon
Francine Rendu
spellingShingle Jean-Marie Launay
Muriel Del Pino
Gilles Chironi
Jacques Callebert
Katell Peoc'h
Jean-Louis Mégnien
Jacques Mallet
Alain Simon
Francine Rendu
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
PLoS ONE
author_facet Jean-Marie Launay
Muriel Del Pino
Gilles Chironi
Jacques Callebert
Katell Peoc'h
Jean-Louis Mégnien
Jacques Mallet
Alain Simon
Francine Rendu
author_sort Jean-Marie Launay
title Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
title_short Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
title_full Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
title_fullStr Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
title_full_unstemmed Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
title_sort smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2009-11-01
description <h4>Background</h4>Postulating that serotonin (5-HT), released from smoking-activated platelets could be involved in smoking-induced vascular modifications, we studied its catabolism in a series of 115 men distributed as current smokers (S), never smokers (NS) and former smokers (FS) who had stopped smoking for a mean of 13 years.<h4>Methodology/principal findings</h4>5-HT, monoamine oxidase (MAO-B) activities and amounts were measured in platelets, and 5-hydroxyindolacetic acid (5-HIAA)--the 5-HT/MAO catabolite--in plasma samples. Both platelet 5-HT and plasma 5-HIAA levels were correlated with the 10-year cardiovascular Framingham relative risk (P<0.01), but these correlations became non-significant after adjustment for smoking status, underlining that the determining risk factor among those taken into account in the Framingham risk calculation was smoking. Surprisingly, the platelet 5-HT content was similar in S and NS but lower in FS with a parallel higher plasma level of 5-HIAA in FS. This was unforeseen since MAO-B activity was inhibited during smoking (P<0.00001). It was, however, consistent with a higher enzyme protein concentration found in S and FS than in NS (P<0.001). It thus appears that MAO inhibition during smoking was compensated by a higher synthesis. To investigate the persistent increase in MAO-B protein concentration, a study of the methylation of its gene promoter was undertaken in a small supplementary cohort of similar subjects. We found that the methylation frequency of the MAOB gene promoter was markedly lower (P<0.0001) for S and FS vs. NS due to cigarette smoke-induced increase of nucleic acid demethylase activity.<h4>Conclusions/significance</h4>This is one of the first reports that smoking induces an epigenetic modification. A better understanding of the epigenome may help to further elucidate the physiopathology and the development of new therapeutic approaches to tobacco addiction. The results could have a larger impact than cardiovascular damage, considering that MAO-dependent 5-HT catabolism is also involved in addiction, predisposition to cancer, behaviour and mental health.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19956754/?tool=EBI
work_keys_str_mv AT jeanmarielaunay smokinginduceslonglastingeffectsthroughamonoamineoxidaseepigeneticregulation
AT murieldelpino smokinginduceslonglastingeffectsthroughamonoamineoxidaseepigeneticregulation
AT gilleschironi smokinginduceslonglastingeffectsthroughamonoamineoxidaseepigeneticregulation
AT jacquescallebert smokinginduceslonglastingeffectsthroughamonoamineoxidaseepigeneticregulation
AT katellpeoch smokinginduceslonglastingeffectsthroughamonoamineoxidaseepigeneticregulation
AT jeanlouismegnien smokinginduceslonglastingeffectsthroughamonoamineoxidaseepigeneticregulation
AT jacquesmallet smokinginduceslonglastingeffectsthroughamonoamineoxidaseepigeneticregulation
AT alainsimon smokinginduceslonglastingeffectsthroughamonoamineoxidaseepigeneticregulation
AT francinerendu smokinginduceslonglastingeffectsthroughamonoamineoxidaseepigeneticregulation
_version_ 1714812364924125184